Antagonist derivatives of the vitronectin receptor
US6838453B2 · kind B2 · utility
5Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2001 |
| Grant date | Jan 4, 2005 |
| Priority date | — |
| Expiry date | May 7, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns vitronectin receptor antagonist compounds of formula (3): R1—Y—A—B—D—E—F—G wherein R1, Y, A, B, D, E, F, and G are as defined in the description, their physiologically acceptable salts and their prodrugs, methods for preparing compounds of formula (I), their use, in particular as medicine and pharmaceutical compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.